Abcellera Biologics Inc
NASDAQ:ABCL

Watchlist Manager
Abcellera Biologics Inc Logo
Abcellera Biologics Inc
NASDAQ:ABCL
Watchlist
Price: 2.64 USD -2.94% Market Closed
Market Cap: 777.9m USD
Have any thoughts about
Abcellera Biologics Inc?
Write Note

Abcellera Biologics Inc
Net Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Abcellera Biologics Inc
Net Income Peer Comparison

Comparables:
ARCH
RP
IOT

Competitive Net Income Analysis
Latest Figures & CAGR of Competitors

Company Net Income CAGR 3Y CAGR 5Y CAGR 10Y
Abcellera Biologics Inc
NASDAQ:ABCL
Net Income
-$146.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Arch Biopartners Inc
XTSX:ARCH
Net Income
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Replicel Life Sciences Inc
XTSX:RP
Net Income
-CA$69.3k
CAGR 3-Years
67%
CAGR 5-Years
51%
CAGR 10-Years
N/A
Innovotech Inc
XTSX:IOT
Net Income
-CA$364.5k
CAGR 3-Years
N/A
CAGR 5-Years
-119%
CAGR 10-Years
7%

See Also

What is Abcellera Biologics Inc's Net Income?
Net Income
-146.4m USD

Based on the financial report for Dec 31, 2023, Abcellera Biologics Inc's Net Income amounts to -146.4m USD.

Back to Top